We investigated whether lowering of fasting homocysteine concentrations, either with folic acid or with betaine supplementation, differentially affects vascular function, a surrogate marker for risk of cardiovascular disease, in healthy volunteers. As yet, it remains uncertain whether a high concentration of homocysteine itself or whether a low folate status--its main determinant--is involved in the pathogenesis of cardiovascular disease. To shed light on this issue, we performed this study.
CITATION STYLE
Olthof, M. R., Bots, M. L., Katan, M. B., & Verhoef, P. (2006). Effect of Folic Acid and Betaine Supplementation on Flow-Mediated Dilation: A Randomized, Controlled Study in Healthy Volunteers. PLoS Clinical Trials, 1(2), e10. https://doi.org/10.1371/journal.pctr.0010010
Mendeley helps you to discover research relevant for your work.